John W. Davis, MD, presented “The Optimal Nadir T Level on ADT Is <20mg/mL” during the 29th Annual International Prostate Cancer Update on January 26, 2019 in Beaver Creek, Colorado.

How to cite: Davis, John W. “The Optimal Nadir T Level on ADT Is <20mg/mL” January 26, 2019. Accessed Nov 2019. https://grandroundsinurology.com/the-optimal-nadir-t-level-on-adt-is/

The Optimal Nadir T Level on ADT Is <20mg/mL

John W. Davis, MD, debates the pros of using <20mg/mL as a threshold for the optimal nadir level of serum testosterone in prostate cancer patients treated with ADT.

Summary:

John W. Davis, MD, debates the pros of using <20mg/mL as a threshold for the optimal nadir level of serum testosterone in prostate cancer patients treated with androgen deprivation therapy (ADT). Dr. Davis reviews commonly-held perspectives on maintaining testosterone over 20 mg/mL on ADT and how these perspectives relate to ADT predictions. He then reviews studies focusing on the connection between the M1 space and T levels.

About the International Prostate Cancer Update

The International Prostate Cancer Update (IPCU) is an annual, multi-day CME conference focused on prostate cancer treatment updates. The conference’s faculty consists of international experts, and the event caters to urologists, medical oncologists, radiation oncologists, and other healthcare professionals. Topics encompass prostate cancer management, from diagnosis to treating advanced and metastatic disease. Dr. Davis presented this lecture during the 29th IPCU in 2019. Please visit this page in order to learn more about future IPCU meetings.